The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases

Mangen M-JJ, Plaß D, Havelaar AH, Gibbons CL, Cassini A, Muehlberger N, van Lier A, Haagsma JA, Brooke RJ, Lai T, de Waure C, et al. (2013)
Plos One 8(11): e79740.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Mangen, Marie-Josee J.; Plaß, DietrichUniBi; Havelaar, Arie H.; Gibbons, Cheryl L.; Cassini, Alessandro; Muehlberger, Nikolai; van Lier, Alies; Haagsma, Juanita A.; Brooke, R. John; Lai, Taavi; de Waure, Chiara; Kramarz, Piotr
Alle
Abstract / Bemerkung
In 2009, the European Centre for Disease Prevention and Control initiated the 'Burden of Communicable Diseases in Europe (BCoDE)' project to generate evidence-based and comparable burden-of-disease estimates of infectious diseases in Europe. The burden-of-disease metric used was the Disability-Adjusted Life Year (DALY), composed of years of life lost due to premature death (YLL) and due to disability (YLD). To better represent infectious diseases, a pathogen-based approach was used linking incident cases to sequelae through outcome trees. Health outcomes were included if an evidence-based causal relationship between infection and outcome was established. Life expectancy and disability weights were taken from the Global Burden of Disease Study and alternative studies. Disease progression parameters were based on literature. Country-specific incidence was based on surveillance data corrected for underestimation. Non-typhoidal Salmonella spp. and Campylobacter spp. were used for illustration. Using the incidence-and pathogen-based DALY approach the total burden for Salmonella spp. and Campylobacter spp. was estimated at 730 DALYs and at 1,780 DALYs per year in the Netherlands (average of 2005-2007). Sequelae accounted for 56% and 82% of the total burden of Salmonella spp. and Campylobacter spp., respectively. The incidence-and pathogen-based DALY methodology allows in the case of infectious diseases a more comprehensive calculation of the disease burden as subsequent sequelae are fully taken into account. Not considering subsequent sequelae would strongly underestimate the burden of infectious diseases. Estimates can be used to support prioritisation and comparison of infectious diseases and other health conditions, both within a country and between countries.
Erscheinungsjahr
2013
Zeitschriftentitel
Plos One
Band
8
Ausgabe
11
Art.-Nr.
e79740
ISSN
1932-6203
eISSN
1932-6203
Page URI
https://pub.uni-bielefeld.de/record/2645284

Zitieren

Mangen M-JJ, Plaß D, Havelaar AH, et al. The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases. Plos One. 2013;8(11): e79740.
Mangen, M. - J. J., Plaß, D., Havelaar, A. H., Gibbons, C. L., Cassini, A., Muehlberger, N., van Lier, A., et al. (2013). The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases. Plos One, 8(11), e79740. doi:10.1371/journal.pone.0079740
Mangen, Marie-Josee J., Plaß, Dietrich, Havelaar, Arie H., Gibbons, Cheryl L., Cassini, Alessandro, Muehlberger, Nikolai, van Lier, Alies, et al. 2013. “The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases”. Plos One 8 (11): e79740.
Mangen, M. - J. J., Plaß, D., Havelaar, A. H., Gibbons, C. L., Cassini, A., Muehlberger, N., van Lier, A., Haagsma, J. A., Brooke, R. J., Lai, T., et al. (2013). The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases. Plos One 8:e79740.
Mangen, M.-J.J., et al., 2013. The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases. Plos One, 8(11): e79740.
M.-J.J. Mangen, et al., “The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases”, Plos One, vol. 8, 2013, : e79740.
Mangen, M.-J.J., Plaß, D., Havelaar, A.H., Gibbons, C.L., Cassini, A., Muehlberger, N., van Lier, A., Haagsma, J.A., Brooke, R.J., Lai, T., de Waure, C., Kramarz, P., Kretzschmar, M.E.E.: The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases. Plos One. 8, : e79740 (2013).
Mangen, Marie-Josee J., Plaß, Dietrich, Havelaar, Arie H., Gibbons, Cheryl L., Cassini, Alessandro, Muehlberger, Nikolai, van Lier, Alies, Haagsma, Juanita A., Brooke, R. John, Lai, Taavi, de Waure, Chiara, Kramarz, Piotr, and Kretzschmar, Mirjam E. E. “The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious Diseases”. Plos One 8.11 (2013): e79740.

37 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.
Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, Ouakrim DA, Oliveira TC, Struelens MJ, Suetens C, Monnet DL, Burden of AMR Collaborative Group., Lancet Infect Dis 19(1), 2019
PMID: 30409683
Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands.
van Lier A, de Gier B, McDonald SA, Mangen MJ, van Wijhe M, Sanders EAM, Kretzschmar ME, van Vliet H, de Melker HE., Euro Surveill 24(18), 2019
PMID: 31064637
Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands.
de Gier B, van Kassel MN, Sanders EAM, van de Beek D, Hahné SJM, van der Ende A, Bijlsma MW., PLoS One 14(5), 2019
PMID: 31071191
A social cost-benefit analysis of two One Health interventions to prevent toxoplasmosis.
Suijkerbuijk AWM, Over EAB, Opsteegh M, Deng H, Gils PFV, Bonačić Marinović AA, Lambooij M, Polder JJ, Feenstra TL, Giessen JWBV, Wit GA, Mangen MJ., PLoS One 14(5), 2019
PMID: 31075130
The disease burden associated with Campylobacter spp. in Germany, 2014.
Lackner J, Weiss M, Müller-Graf C, Greiner M., PLoS One 14(5), 2019
PMID: 31091282
Burden of disease and economic impact of human Streptococcus suis infection in Viet Nam.
Huong VTL, Turner HC, Kinh NV, Thai PQ, Hoa NT, Horby P, van Doorn HR, Wertheim HFL., Trans R Soc Trop Med Hyg 113(6), 2019
PMID: 30809669
Disease burden of methylmercury in the German birth cohort 2014.
Lackner J, Weiss M, Müller-Graf C, Greiner M., PLoS One 13(1), 2018
PMID: 29324759
Disability weights for infectious diseases in four European countries: comparison between countries and across respondent characteristics.
Maertens de Noordhout C, Devleesschauwer B, Salomon JA, Turner H, Cassini A, Colzani E, Speybroeck N, Polinder S, Kretzschmar ME, Havelaar AH, Haagsma JA., Eur J Public Health 28(1), 2018
PMID: 29020343
Methodology for computing the burden of disease of adverse events following immunization.
McDonald SA, Nijsten D, Bollaerts K, Bauwens J, Praet N, van der Sande M, Bauchau V, de Smedt T, Sturkenboom M, Hahné S., Pharmacoepidemiol Drug Saf 27(7), 2018
PMID: 29575242
Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013.
Cassini A, Colzani E, Pini A, Mangen MJ, Plass D, McDonald SA, Maringhini G, van Lier A, Haagsma JA, Havelaar AH, Kramarz P, Kretzschmar ME, On Behalf Of The BCoDE Consortium., Euro Surveill 23(16), 2018
PMID: 29692315
A Software Tool for Estimation of Burden of Infectious Diseases in Europe Using Incidence-Based Disability Adjusted Life Years.
Colzani E, Cassini A, Lewandowski D, Mangen MJ, Plass D, McDonald SA, van Lier A, Haagsma JA, Maringhini G, Pini A, Kramarz P, Kretzschmar ME., PLoS One 12(1), 2017
PMID: 28107447
Estimating the annual burden of tick-borne encephalitis to inform vaccination policy, Slovenia, 2009 to 2013.
Fafangel M, Cassini A, Colzani E, Klavs I, Grgič Vitek M, Učakar V, Muehlen M, Vudrag M, Kraigher A., Euro Surveill 22(16), 2017
PMID: 28449731
Burden and spectrum of infectious disease in Germany 2009-2014: a multicentre study from Berlin's Municipal Hospitals.
Katchanov J, Wöstmann K, Tominski D, Jefferys L, Liedtke A, Schneider A, Slevogt H, Arastéh K, Stocker H., Infection 44(2), 2016
PMID: 26311655
Risk Prioritization Tool to Identify the Public Health Risks of Wildlife Trade: The Case of Rodents from Latin America.
Bueno I, Smith KM, Sampedro F, Machalaba CC, Karesh WB, Travis DA., Zoonoses Public Health 63(4), 2016
PMID: 26414429
Burden of four vaccine preventable diseases in older adults.
Kristensen M, van Lier A, Eilers R, McDonald SA, Opstelten W, van der Maas N, van der Hoek W, Kretzschmar ME, Nielen MM, de Melker HE., Vaccine 34(7), 2016
PMID: 26752065
Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011.
van Lier A, McDonald SA, Bouwknegt M, EPI group, Kretzschmar ME, Havelaar AH, Mangen MJ, Wallinga J, de Melker HE., PLoS One 11(4), 2016
PMID: 27097024
The Burden of Zoonoses in Kyrgyzstan: A Systematic Review.
Counotte MJ, Minbaeva G, Usubalieva J, Abdykerimov K, Torgerson PR., PLoS Negl Trop Dis 10(7), 2016
PMID: 27387925
Applying QMRA and DALY to assess health risks from river bathing.
Timm C, Luther S, Jurzik L, Hamza IA, Kistemann T., Int J Hyg Environ Health 219(7 pt b), 2016
PMID: 27590614
Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.
Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T, Haller S, Harder T, Klingeberg A, Sixtensson M, Velasco E, Weiß B, Kramarz P, Monnet DL, Kretzschmar ME, Suetens C., PLoS Med 13(10), 2016
PMID: 27755545
The impact of individual-level heterogeneity on estimated infectious disease burden: a simulation study.
McDonald SA, Devleesschauwer B, Wallinga J., Popul Health Metr 14(), 2016
PMID: 27931225
The low global burden of trichinellosis: evidence and implications.
Devleesschauwer B, Praet N, Speybroeck N, Torgerson PR, Haagsma JA, De Smet K, Murrell KD, Pozio E, Dorny P., Int J Parasitol 45(2-3), 2015
PMID: 24953055
Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011.
Mangen MJ, Bouwknegt M, Friesema IH, Haagsma JA, Kortbeek LM, Tariq L, Wilson M, van Pelt W, Havelaar AH., Int J Food Microbiol 196(), 2015
PMID: 25528537
Assessing disability weights based on the responses of 30,660 people from four European countries.
Haagsma JA, Maertens de Noordhout C, Polinder S, Vos T, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar ME, Speybroeck N, Salomon JA., Popul Health Metr 13(), 2015
PMID: 26778920
Incidence and Costs of Clostridium difficile Infections in Canada.
Levy AR, Szabo SM, Lozano-Ortega G, Lloyd-Smith E, Leung V, Lawrence R, Romney MG., Open Forum Infect Dis 2(3), 2015
PMID: 26191534
The burden of Lyme borreliosis expressed in disability-adjusted life years.
van den Wijngaard CC, Hofhuis A, Harms MG, Haagsma JA, Wong A, de Wit GA, Havelaar AH, Lugnér AK, Suijkerbuijk AW, van Pelt W., Eur J Public Health 25(6), 2015
PMID: 26082446
Trends in the Burden of Hepatitis B in a Southern Brazilian State.
Marcon CE, Schneider IJ, Schuelter-Trevisol F, Traebert J., Hepat Mon 15(11), 2015
PMID: 26834790
Methodological Framework for World Health Organization Estimates of the Global Burden of Foodborne Disease.
Devleesschauwer B, Haagsma JA, Angulo FJ, Bellinger DC, Cole D, Döpfer D, Fazil A, Fèvre EM, Gibb HJ, Hald T, Kirk MD, Lake RJ, Maertens de Noordhout C, Mathers CD, McDonald SA, Pires SM, Speybroeck N, Thomas MK, Torgerson PR, Wu F, Havelaar AH, Praet N., PLoS One 10(12), 2015
PMID: 26633883
Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods.
Gibbons CL, Mangen MJ, Plass D, Havelaar AH, Brooke RJ, Kramarz P, Peterson KL, Stuurman AL, Cassini A, Fèvre EM, Kretzschmar ME, Burden of Communicable diseases in Europe (BCoDE) consortium., BMC Public Health 14(), 2014
PMID: 24517715
Impact of measles national vaccination coverage on burden of measles across 29 Member States of the European Union and European Economic Area, 2006-2011.
Colzani E, McDonald SA, Carrillo-Santisteve P, Busana MC, Lopalco P, Cassini A., Vaccine 32(16), 2014
PMID: 24530930
DALY calculation in practice: a stepwise approach.
Devleesschauwer B, Havelaar AH, Maertens de Noordhout C, Haagsma JA, Praet N, Dorny P, Duchateau L, Torgerson PR, Van Oyen H, Speybroeck N., Int J Public Health 59(3), 2014
PMID: 24748107
Relevance of Campylobacter to public health--the need for a One Health approach.
Gölz G, Rosner B, Hofreuter D, Josenhans C, Kreienbrock L, Löwenstein A, Schielke A, Stark K, Suerbaum S, Wieler LH, Alter T., Int J Med Microbiol 304(7), 2014
PMID: 25266744
The global burden of listeriosis: a systematic review and meta-analysis.
de Noordhout CM, Devleesschauwer B, Angulo FJ, Verbeke G, Haagsma J, Kirk M, Havelaar A, Speybroeck N., Lancet Infect Dis 14(11), 2014
PMID: 25241232
Disease burden of selected gastrointestinal pathogens in Australia, 2010.
Gibney KB, O'Toole J, Sinclair M, Leder K., Int J Infect Dis 28(), 2014
PMID: 25281904

44 References

Daten bereitgestellt von Europe PubMed Central.

The global burden of disease in 1990 : summary results, sensitivity analysis and future directions. Bull World Health Organ
AUTHOR UNKNOWN, 1994
Global and regional cause-of-death patterns in 1990. Bull World Health Organ
AUTHOR UNKNOWN, 1994
Quantifying disability: data, methods and results. Bull World Health Organ
AUTHOR UNKNOWN, 1994
Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ
AUTHOR UNKNOWN, 1994

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
Measuring burden of disease in Estonia to support public health policy.
Lai T, Habicht J, Kiivet RA., Eur J Public Health 19(5), 2009
PMID: 19401358
Disability weights for diseases: A modified protocol and results for a Western European region
AUTHOR UNKNOWN, 2000

AUTHOR UNKNOWN, 0
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ., Lancet 367(9524), 2006
PMID: 16731270
New methodology for estimating the burden of infectious diseases in Europe.
Kretzschmar M, Mangen MJ, Pinheiro P, Jahn B, Fevre EM, Longhi S, Lai T, Havelaar AH, Stein C, Cassini A, Kramarz P; BCoDE consortium, Havelaar A, Kretzschmar M, van Lier A, McDonald S, Brooke J, Haagsma J, Mangen MJ, de Wit A, Kramer A, Pinheiro P, Plass D, Fevre E, Gibbons C, Franco E, Longhi S, Ricciardi W, de Waure C, Jahn B, Muhlberger N, Siebert U, Lai T, Matsi A, Ruutel K, Cassini A, Colzani E, Kramarz P, Achterberg P, Amato A, Coutinho R, Nanda A, Salminen M, Vos T., PLoS Med. 9(4), 2012
PMID: 22529750
The burden of infectious diseases in Europe: a pilot study
AUTHOR UNKNOWN, 2007

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health.
Gold MR, Stevenson D, Fryback DG., Annu Rev Public Health 23(), 2001
PMID: 11910057

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
Integrated approaches for the public health prioritization of foodborne and zoonotic pathogens.
Mangen MJ, Batz MB, Kasbohrer A, Hald T, Morris JG Jr, Taylor M, Havelaar AH., Risk Anal. 30(5), 2009
PMID: 19765248

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
Understanding DALYs (disability-adjusted life years).
Murray CJ, Acharya AK., J Health Econ 16(6), 1997
PMID: 10176780

AUTHOR UNKNOWN, 0
Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157.
Havelaar AH, Van Duynhoven YT, Nauta MJ, Bouwknegt M, Heuvelink AE, De Wit GA, Nieuwenhuizen MG, van de Kar NC., Epidemiol. Infect. 132(3), 2004
PMID: 15188716
Health burden in the Netherlands due to infection with thermophilic Campylobacter spp.
Havelaar AH, de Wit MA, van Koningsveld R, van Kempen E., Epidemiol. Infect. 125(3), 2000
PMID: 11218201
The costs of human Campylobacter infections and sequelae in the Netherlands: a DALY and cost-of-illness approach
AUTHOR UNKNOWN, 2005

AUTHOR UNKNOWN, 0
Foodborne illness acquired in the United States–unspecified agents. Emerg Infect Dis
AUTHOR UNKNOWN, 2011

AUTHOR UNKNOWN, 0
Disease burden of foodborne pathogens in the Netherlands, 2009. Int J Food Microbiol
AUTHOR UNKNOWN, 2012

AUTHOR UNKNOWN, 0
Disease burden of post-infectious irritable bowel syndrome in The Netherlands.
Haagsma JA, Siersema PD, De Wit NJ, Havelaar AH., Epidemiol. Infect. 138(11), 2010
PMID: 20223049

AUTHOR UNKNOWN, 0
Clinical, epidemiological and pathogentic aspects of reactive arthritis
AUTHOR UNKNOWN, 1994

AUTHOR UNKNOWN, 0
Laboratory surveillance of bacterial gastroenteric pathogens in The Netherlands, 1991-2001.
van Pelt W, de Wit MA, Wannet WJ, Ligtvoet EJ, Widdowson MA, van Duynhoven YT., Epidemiol. Infect. 130(3), 2003
PMID: 12825727
Estimating the true incidence of campylobacteriosis and salmonellosis in the EU
AUTHOR UNKNOWN, 2013

AUTHOR UNKNOWN, 0
The burden of disease in Zimbabwe in 1997 as measured by disability-adjusted life years lost.
Chapman G, Hansen KS, Jelsma J, Ndhlovu C, Piotti B, Byskov J, Vos T., Trop. Med. Int. Health 11(5), 2006
PMID: 16640619
The burden of disease and injury in the United States 1996.
Michaud CM, McKenna MT, Begg S, Tomijima N, Majmudar M, Bulzacchelli MT, Ebrahim S, Ezzati M, Salomon JA, Kreiser JG, Hogan M, Murray CJ., Popul Health Metr 4(), 2006
PMID: 17049081
Systematic review of foodborne burden of disease studies: quality assessment of data and methodology.
Haagsma JA, Polinder S, Stein CE, Havelaar AH., Int. J. Food Microbiol. 166(1), 2013
PMID: 23827806
Risk Ranking for Foodborne Microbial Hazards in New Zealand: Burden of Disease Estimates
AUTHOR UNKNOWN, 2010

AUTHOR UNKNOWN, 0
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 24278167
PubMed | Europe PMC

Suchen in

Google Scholar